Tunable beam steering along orthogonal directions has been demonstrated. Such tunable stimuli-responsive soft materials fabricated with artificial chiral switches show great potential in optics, photonics, and beyond.Sufferers of cystic fibrosis are at extremely high risk for contracting chronic lung infections. Over their lifetime, one bacterial strain in particular, Pseudomonas aeruginosa, becomes the dominant pathogen. Bacterial strains incur loss-of-function mutations in the mucA gene that lead to a mucoid conversion, resulting in copious secretion of the exopolysaccharide alginate. Strategies that stop the production of alginate in mucoid Pseudomonas aeruginosa infections are therefore of paramount importance. To aid in this, a series of sugar nucleotide tools to probe an enzyme critical to alginate biosynthesis, guanosine diphosphate mannose dehydrogenase (GMD), have been developed. GMD catalyzes the irreversible formation of the alginate building block, guanosine diphosphate mannuronic acid. Using a chemoenzymatic strategy, we accessed a series of modified sugar nucleotides, identifying a C6-amide derivative of guanosine diphosphate mannose as a micromolar inhibitor of GMD. This discovery provides a framework for wider inhibition strategies against GMD to be developed.Di Mascio, M, Ade, J, Musham, C, Girard, O, and Bradley, PS. https://www.selleckchem.com/products/rhps4-nsc714187.html Soccer-specific reactive repeated-sprint ability in elite youth soccer players maturation trends and association with various physical performance tests. J Strength Cond Res 34(12) 3538-3545, 2020-Repeated-sprint ability is an important physical prerequisite for competitive soccer and deviates for players in various stages of growth and development. Thus, this study investigated reactive repeated-sprint ability in elite youth soccer players in relation to maturation (age at peak height velocity) and its association with performance of other physical tests. Elite male youth players from an English Premier League academy (U12, n = 8; U13, n = 11; U14, n = 15; U15, n = 6; U16, n = 10; and U18, n = 13) completed the reactive repeated-sprint test (RRST; 8 × 30-m sprints with 30-second active recovery), and other physical tests including the Yo-Yo intermittent recovery test level 2 (Yo-Yo IR2), arrowhead agility test, countermovement jump test with arms (CMJA), in addition to 10- and 20-m straight-line sprints. Reactive repeated-sprint test (RRST) performance (total time across 8 sprints) progressively improved from U12 to U16 (p 0.05; ES less then 0.3). Correlation magnitudes between performance on the RRST and other tests were trivial to moderate for the Yo-Yo IR2 (r = -0.15 to 0.42), moderate to very large for the arrowhead agility test (r = 0.48-0.90), moderate to large for CMJA (r = -0.43 to 0.66), and trivial to large for 10- and 20-m sprints (r = 0.05-0.61). The RRST was sensitive at tracking maturation trends in elite youth players, although performance improvements were not as marked from 15 to 16 years of age. RRST performance correlates with several physical qualities decisive for competitive soccer (agility, speed, power, and aerobic endurance). Psoriasis is considered a systemic disease associated with metabolic abnormalities, and it is important to understand the mechanisms by which metabolism affects pathophysiological processes both holistically and systematically. Metabolites are closely related to disease phenotypes, especially in systemic diseases under multifactorial modulation. The emergence of metabolomics has provided information regarding metabolite changes in lesions and circulation and deepened our understanding of the association between metabolic reprogramming and psoriasis. Metabolomics has great potential for the development of effective biomarkers for clinical diagnosis, therapeutic monitoring, prediction of the efficacy of psoriasis management, and further discovery of new metabolism-based therapeutic targets. Psoriasis is considered a systemic disease associated with metabolic abnormalities, and it is important to understand the mechanisms by which metabolism affects pathophysiological processes both holistically and systematically. Metabolites are closely related to disease phenotypes, especially in systemic diseases under multifactorial modulation. The emergence of metabolomics has provided information regarding metabolite changes in lesions and circulation and deepened our understanding of the association between metabolic reprogramming and psoriasis. Metabolomics has great potential for the development of effective biomarkers for clinical diagnosis, therapeutic monitoring, prediction of the efficacy of psoriasis management, and further discovery of new metabolism-based therapeutic targets. Antimicrobial peptides (AMPs) are small molecules produced by a myriad of cells and play important roles not only in protecting against infections and sustaining skin barrier homeostasis but also in contributing to immune dysregulation under pathological conditions. Recently, increasing evidence has indicated that AMPs, including cathelicidin (LL-37), human β-defensins, S100 proteins, lipocalin 2, and RNase 7, are highly expressed in psoriatic skin lesions. These peptides broadly regulate immunity by interacting with various immune cells and linking innate and adaptive immune responses during the progression of psoriasis. In this review, we summarize the recent findings regarding AMPs in the pathogenesis of psoriasis with a main focus on their immunomodulatory abilities. Antimicrobial peptides (AMPs) are small molecules produced by a myriad of cells and play important roles not only in protecting against infections and sustaining skin barrier homeostasis but also in contributing to immune dysregulation under pathological conditions. Recently, increasing evidence has indicated that AMPs, including cathelicidin (LL-37), human β-defensins, S100 proteins, lipocalin 2, and RNase 7, are highly expressed in psoriatic skin lesions. These peptides broadly regulate immunity by interacting with various immune cells and linking innate and adaptive immune responses during the progression of psoriasis. In this review, we summarize the recent findings regarding AMPs in the pathogenesis of psoriasis with a main focus on their immunomodulatory abilities.